Regulation & law · 02/12/1996Updated: 10/18/2026 · 1 min read
National Institute of Environmental Health Sciences Seeks Company to Develop Gene Therapy for Metastatic Prostate Cancer
Summary
The National Institute of Environmental Health Sciences is seeking a company to collaborate on the development of gene therapy protocols using the KAI1 metastasis suppressor gene, which has been linked to the progression of prostate cancer to a metastatic state.
Original source language: Federal Register — All DocumentsOpen original release →